CN Bio’s flagship liver on a chip platform, LiverChip, has been featured both in a technology snapshot in the March 23rd issue of Businessweek and in a separate article published on the Bloomberg website. The Business week snapshot is available online here and the full Bloomberg article is available here.

Bloomberg TV also featured the story with the video on April the 29th, available here.

Dr Emma Sceats, CN Bio’s Chief Operating Officer, said “It’s an honour to have our technology covered in such a well-regarded magazine. Our aim is to increase awareness of our technologies in all markets where liver diseases and infections, such as hepatitis B, are prevalent so that we can forge new partnerships with pharmaceutical companies wherever they are in the world.”

 

← Back To All News


We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch

We like to contact you about: exciting events, campaigns and information about the new products (please note we DO NOT pass on your details to any other organisations), you can opt out of receiving communications at any time.
By submitting your message, you acknowledge that you have read and understood the Privacy Policy

I confirm that I would like CN Bio to stay in touch